Vista Pharmaceuticals Live BSE/NSE | Vista Pharmaceuticals Fundamenta data | Vista Pharmaceuticals Balance sheet | Vista Pharmaceuticals Quarterly Results | Vista Pharmaceuticals Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

32.64
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

42.93
N/A
0.85

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

44.19
17.71
8.72

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-14.61
-16.61

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-7.12
-9.06

P:E (Median)

8 Years
5 Years
3 Years

36.50
51.74
49.51

P:BV (Average)

8 Years
5 Years
3 Years

0.82
0.82
0.82

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.50
17.02
13.20

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 7 -100% 1 12 -93% 7 7 -4% 8 6 38%
Expenses 0 9 -99% 5 11 -58% 6 8 -23% 7 5 38%
EBITDA 0 -2 - -4 1 - 1 -1 - 1 1 34%
EBIDTM 0% -33% -483% 7% 10% -12% 10% 10%
Other Income 0 3 -100% 0 0 1233% 0 2 -98% 0 1 -81%
Interest 1 0 49% 0 0 -12% 0 0 -21% 0 0 7%
Depreciation 0 0 -47% 0 0 0% 0 0 -3% 0 0 -3%
PBT -1 0 - -4 0 - 0 0 -54% 0 0 -74%
Tax -1 0 - 0 0 - 0 0 440% 0 0 -95%
PAT 0 0 - -4 1 - 0 0 - 0 0 11%
PATM 0% 1% -516% 5% -3% 1% 1% 2%
EPS -0.09 0.03 - -1.14 0.18 - -0.06 0.02 - 0.03 0.03 0%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 16 31 29 24 15 14 8 7 4 6 1 Net Sales Growth -51% 7% 20% 57% 12% 66% 11% 106% -36% 609% Cost Of Goods Sold 16 25 16 16 10 7 5 4 2 3 0 Gross Profit -1 6 13 8 6 6 4 3 1 2 0 GP Margin -4% 18% 45% 33% 38% 46% 45% 41% 38% 43% 46% Total Expenditure 18 30 24 21 13 11 7 7 5 5 2 Power & Fuel Cost - 0 1 0 0 1 0 0 0 0 0 % Of Sales - 1% 2% 2% 2% 4% 6% 5% 7% 5% 28% Employee Cost - 1 1 1 1 1 1 1 1 1 1 % Of Sales - 4% 3% 3% 5% 5% 7% 9% 19% 12% 65% Manufacturing Exp. - 0 1 0 1 1 1 1 0 1 0 % Of Sales - 1% 3% 2% 5% 8% 10% 8% 13% 9% 28% General & Admin Exp. - 1 1 1 1 1 0 0 0 0 0 % Of Sales - 2% 4% 3% 4% 4% 5% 5% 11% 6% 50% Selling & Distn. Exp. - 0 1 2 0 1 0 0 0 0 0 % Of Sales - 1% 5% 7% 3% 5% 2% 3% 12% 6% 9% Miscellaneous Exp. - 1 3 1 0 0 0 0 0 0 0 % Of Sales - 4% 9% 4% 1% 1% 0% 0% 1% 0% 1% EBITDA -3 1 5 3 3 3 1 1 -1 0 -1 EBITDA Margin -16% 4% 18% 13% 17% 20% 15% 11% -25% 4% -134% Other Income 1 3 0 0 0 0 0 0 0 0 0 Interest 2 2 2 1 1 0 0 0 0 0 0 Depreciation 1 1 1 1 1 1 1 1 1 1 0 PBT -5 1 3 1 1 1 0 0 -2 0 -1 Tax 0 0 1 0 0 0 0 0 0 0 0 Tax Rate 6% 18% 23% -2% 7% -9% 2% 53% -8% 0% 0% PAT -5 1 2 1 1 1 0 0 -2 0 -1 PAT before Minority Interest -5 1 2 1 1 1 0 0 -2 0 -1 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin -30% 3% 8% 5% 5% 10% 6% 1% -46% -5% -169% PAT Growth -604% -57% 75% 62% -43% 189% 488% 105% -472% 79% EPS -1.26 0.26 0.60 0.34 0.21 0.37 0.13 0.02 -0.45 -0.08 -0.37

Description

TTM

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Net Sales

Net Sales Growth

-51%

20%

57%

12%

66%

11%

106%

-36%

609%

Cost Of Goods Sold

Gross Profit

-1

GP Margin

-4%

18%

45%

33%

38%

46%

45%

41%

38%

43%

46%

Total Expenditure

Power & Fuel Cost

% Of Sales

28%

Employee Cost

% Of Sales

19%

12%

65%

Manufacturing Exp.

% Of Sales

10%

13%

28%

General & Admin Exp.

% Of Sales

11%

50%

Selling & Distn. Exp.

% Of Sales

12%

Miscellaneous Exp.

% Of Sales

EBITDA

-3

-1

EBITDA Margin

-16%

18%

13%

17%

20%

15%

11%

-25%

-134%

Other Income

Interest

Depreciation

PBT

-5

-2

-1

Tax

Tax Rate

18%

23%

-2%

-9%

53%

-8%

PAT

-5

-2

-1

PAT before Minority Interest

-5

-2

-1

Minority Interest

PAT Margin

-30%

10%

-46%

-5%

-169%

PAT Growth

-604%

-57%

75%

62%

-43%

189%

488%

105%

-472%

79%

EPS

-1.26

0.26

0.60

0.34

0.21

0.37

0.13

0.02

-0.45

-0.08

-0.37

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 36 32 17 11 10 9 9 9 10 11 Share Capital 6 6 5 5 5 15 15 15 15 15 Total Reserves 27 20 11 6 5 -6 -6 -6 -5 -4 Non-Current Liabilities 6 6 5 8 0 0 0 0 0 0 Secured Loans 6 6 6 8 0 0 0 0 0 0 Unsecured Loans 0 0 0 0 0 0 0 0 0 0 Long Term Provisions 0 0 0 0 0 0 0 0 0 0 Current Liabilities 11 15 19 7 12 5 6 6 5 4 Trade Payables 5 9 13 7 8 4 3 2 4 1 Other Current Liabilities 0 0 0 0 0 0 2 4 1 3 Short Term Borrowings 5 5 5 0 4 0 0 0 0 0 Short Term Provisions 0 1 0 1 0 0 0 0 0 0 Total Liabilities 53 53 41 26 23 14 14 15 15 14 Net Block 21 18 13 10 11 12 12 13 13 6 Gross Block 24 20 14 19 18 18 18 18 18 11 Accumulated Depreciation 4 2 1 9 8 7 6 5 5 4 Non Current Assets 29 25 16 10 11 12 13 13 14 14 Capital Work in Progress 9 7 2 0 0 0 0 0 0 7 Non Current Investment 0 0 0 0 0 0 0 0 0 0 Long Term Loans & Adv. 0 0 0 0 0 0 0 0 0 0 Other Non Current Assets 0 0 0 0 0 0 0 0 0 0 Current Assets 23 28 26 16 12 2 2 2 2 1 Current Investments 0 0 0 0 0 0 0 0 0 0 Inventories 11 11 8 3 0 1 1 1 1 0 Sundry Debtors 8 11 9 10 11 1 0 0 0 0 Cash & Bank 1 2 6 0 0 0 0 0 0 0 Other Current Assets 3 2 0 3 0 0 0 0 0 0 Short Term Loans & Adv. 1 2 2 0 0 0 0 0 0 0 Net Current Assets 12 13 7 9 0 -2 -4 -4 -3 -3 Total Assets 53 53 41 26 23 14 14 15 15 14

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Shareholder's Funds

Share Capital

Total Reserves

-6

-5

-4

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

-2

-4

-3

Total Assets

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 3 -5 3 -2 -4 0 0 0 0 1 PBT 1 3 1 1 1 0 0 -2 0 -1 Adjustment 2 3 2 2 1 1 1 1 1 0 Changes in Working Capital 0 -10 -1 -5 -6 -1 -1 1 0 2 Cash after chg. in Working capital 4 -5 3 -2 -4 0 0 0 0 1 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid 0 0 0 0 0 0 0 0 0 0 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -6 -11 -4 0 0 0 0 0 0 -1 Net Fixed Assets -6 -11 2 0 0 0 0 0 0 -1 Net Investments 0 0 0 0 0 0 0 0 0 0 Others 0 0 -6 0 0 0 0 0 0 0 Cash from Financing Activity 1 11 6 3 4 0 0 0 0 0 Net Cash Inflow / Outflow -1 -4 5 0 0 0 0 0 0 0 Opening Cash & Equivalents 2 6 0 0 0 0 0 0 0 0 Closing Cash & Equivalent 1 2 6 0 0 0 0 0 0 0

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Cash From Operating Activity

-5

-2

-4

PBT

-2

-1

Adjustment

Changes in Working Capital

-10

-1

-5

-6

-1

Cash after chg. in Working capital

-5

-2

-4

Interest Paid

Tax Paid

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-6

-11

-4

-1

Net Fixed Assets

-6

-11

-1

Net Investments

Others

-6

Cash from Financing Activity

Net Cash Inflow / Outflow

-1

-4

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 11 9 6 4 4 6 6 6 7 7 ROA 2% 5% 4% 3% 7% 3% 1% -11% -2% -10% ROE 3% 10% 9% 7% 14% 5% 1% -18% -3% -12% ROCE 6% 12% 9% 10% 14% 5% 2% -16% -3% -12% Fixed Asset Turnover 1.40 1.68 1.46 0.83 0.74 0.45 0.41 0.20 0.40 0.08 Receivable days 113 125 142 250 164 45 0 0 0 0 Inventory Days 130 120 82 34 12 45 61 118 52 163 Payable days 90 187 171 189 192 187 143 217 137 92 Cash Conversion Cycle 153 59 52 95 -17 -97 -82 -99 -85 71 Total Debt/Equity 0.34 0.42 0.68 0.70 0.39 0.00 0.00 0.00 0.00 0.00 Interest Cover 2 3 2 2 4 154 23 -128 -31 -487

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Book Value (Rs.)

ROA

-11%

-2%

-10%

ROE

10%

14%

-18%

-3%

-12%

ROCE

12%

10%

14%

-16%

-3%

-12%

Fixed Asset Turnover

1.40

1.68

1.46

0.83

0.74

0.45

0.41

0.20

0.40

0.08

Receivable days

113

125

142

250

164

Inventory Days

130

120

118

163

Payable days

187

171

189

192

187

143

217

137

Cash Conversion Cycle

153

-17

-97

-82

-99

-85

Total Debt/Equity

0.34

0.42

0.68

0.70

0.39

0.00

Interest Cover

154

-128

-31

-487

Vista Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 524711 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Vista Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 524711 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update